{"contacts": [{"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Dominic Kurian"}, {"accession": "MS:1000589", "name": "contact email", "value": "dominic.kurian@roslin.ed.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "University of Edinburgh"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Prof.Stuart Forbes"}, {"accession": "MS:1000589", "name": "contact email", "value": "stuart.forbes@ed.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "MRC Centre for Regenerative Medicine, Little France Drive, University of Edinburgh,  EH16 4UU"}]}], "description": "Cholangiocarcinoma is a cancer of the hepatic bile ducts that is typically detected at a stage too advanced for resection. Additionally, chemotherapy is of limited efficacy, hence, novel therapeutic approaches are urgently required, including targeting of the cancer stroma. A macrophage-derived signal, tumour necrosis factor-like weak inducer of apoptosis (TWEAK), binds to cell-surface fibroblast growth factor-inducible 14 (Fn14), on cholangiocarcinoma cells to induce cytokine and chemokine expression and secretion. These TWEAK-inducible factors from cholangiocarcinoma cells can also affect macrophage polarisation. We characterised proteins secreted by four well-characterised human cholangiocarcinoma cell lines in the presence or absence of recombinant human TWEAK (100 ng/ml), to discover novel TWEAK-inducible factors that could drive pro-tumour niche formation. ", "fullDatasetLinks": [{"accession": "MS:1002488", "name": "MassIVE dataset URI", "value": "http://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=77d332beb7f340e59a46bc392e698c1c"}, {"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://massive.ucsd.edu/MSV000084273/"}], "identifiers": [{"accession": "MS:1002487", "name": "MassIVE dataset identifier", "value": "MSV000084273"}, {"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD015317"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}], "instruments": [{"accession": "MS:1000704", "name": "micrOTOF-Q II"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Cholangiocarcinoma, niche, stroma, TWEAK, Fn14, inflammation"}], "modifications": [{"accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"accession": "MOD:00412", "name": "oxidation"}, {"accession": "UNIMOD:7", "name": "Deamidated"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "33221352"}, {"accession": "MS:1002866", "name": "Reference", "value": "Dwyer BJ, Jarman EJ, Gogoi-Tiwari J, Ferreira-Gonzalez S, Boulter L, Guest RV, Kendall TJ, Kurian D, Kilpatrick AM, Robson AJ, O'Duibhir E, Man TY, Campana L, Starkey Lewis PJ, Wigmore SJ, Olynyk JK, Ramm GA, Tirnitz-Parker JEE, Forbes SJ. TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression. J Hepatol. Epub 2020 Nov 19."}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001468", "name": "taxonomy: common name", "value": "human"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression"}